These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31437412)

  • 41. Antinociceptive effect of intrathecal administration of taurine in rat models of neuropathic pain.
    Terada T; Hara K; Haranishi Y; Sata T
    Can J Anaesth; 2011 Jul; 58(7):630-637. PubMed ID: 21512835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in intrathecal drug delivery.
    De Andres J; Asensio-Samper JM; Fabregat-Cid G
    Curr Opin Anaesthesiol; 2013 Oct; 26(5):594-9. PubMed ID: 23816978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antihyperalgesic and side effects of intrathecal clonidine and tizanidine in a rat model of neuropathic pain.
    Kawamata T; Omote K; Yamamoto H; Toriyabe M; Wada K; Namiki A
    Anesthesiology; 2003 Jun; 98(6):1480-3. PubMed ID: 12766661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.
    Smyth C; Ahmadzai N; Wentzell J; Pardoe A; Tse A; Nguyen T; Goddard Y; Nair S; Poulin PA; Skidmore B; Ansari MT
    Drugs; 2015 Nov; 75(17):1957-80. PubMed ID: 26501979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
    Wermeling DP
    Pharmacotherapy; 2005 Aug; 25(8):1084-94. PubMed ID: 16207099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanical Antiallodynic Effect of Intrathecal Nefopam in a Rat Neuropathic Pain Model.
    Kim KH; Byeon GJ; Kim HY; Baek SH; Shin SW; Koo ST
    J Korean Med Sci; 2015 Aug; 30(8):1189-96. PubMed ID: 26240499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of the 5-HT(7) receptor in the effects of intrathecal nefopam in neuropathic pain in rats.
    Dam LJ; Hai L; Ha YM
    Neurosci Lett; 2014 Apr; 566():50-4. PubMed ID: 24561091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antihyperalgesic effects of intrathecal bupropion, a dopamine and noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
    Hoshino H; Obata H; Nakajima K; Mieda R; Saito S
    Anesth Analg; 2015 Feb; 120(2):460-6. PubMed ID: 25427287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
    Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
    Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
    Papanas N; Ziegler D
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of glucocorticoids on neuropathic pain: a review with emphasis on intrathecal methylprednisolone acetate delivery.
    Rijsdijk M; van Wijck AJ; Kalkman CJ; Yaksh TL
    Anesth Analg; 2014 May; 118(5):1097-112. PubMed ID: 24781577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zucapsaicin for the treatment of neuropathic pain.
    Sałat K; Jakubowska A; Kulig K
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1433-40. PubMed ID: 25171227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrathecal drug delivery.
    Smith HS; Deer TR; Staats PS; Singh V; Sehgal N; Cordner H
    Pain Physician; 2008 Mar; 11(2 Suppl):S89-S104. PubMed ID: 18443642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of naturally occurring peptides for neuropathic spinal cord injury pain.
    Hama A; Sagen J
    Curr Protein Pept Sci; 2013 May; 14(3):218-30. PubMed ID: 23721309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic Interaction Between Dexmedetomidine and Ulinastatin Against Vincristine-Induced Neuropathic Pain in Rats.
    Nie B; Zhang S; Huang Z; Huang J; Chen X; Zheng Y; Bai X; Zeng W; Ouyang H
    J Pain; 2017 Nov; 18(11):1354-1364. PubMed ID: 28690001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ziconotide: a clinical update and pharmacologic review.
    Pope JE; Deer TR
    Expert Opin Pharmacother; 2013 May; 14(7):957-66. PubMed ID: 23537340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain.
    Chen SR; Khan GM; Pan HL
    Anesthesiology; 2001 Oct; 95(4):1007-12. PubMed ID: 11605898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery.
    Deer TR; Smith HS; Cousins M; Doleys DM; Levy RM; Rathmell JP; Staats PS; Wallace M; Webster LR
    Pain Physician; 2010; 13(3):E175-213. PubMed ID: 20495597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxycodone for neuropathic pain and fibromyalgia in adults.
    Gaskell H; Moore RA; Derry S; Stannard C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Study of Different Approaches of Parecoxib Sodium Pretreatment on the Behavior of Rats with Neuropathic Pain.
    Cui W; Yu X; Zhang H
    Cell Biochem Biophys; 2015 May; 72(1):137-40. PubMed ID: 25572054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.